Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's disease and mitophagy: an emerging role for LRRK2
François Singh, Ian G. Ganley
Biochemical Society Transactions (2021) Vol. 49, Iss. 2, pp. 551-562
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The pathogenesis of Parkinson's disease
Huw R. Morris, Maria Grazia Spillantini, Carolyn M. Sue, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 293-304
Open Access | Times Cited: 274
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases
Jie Li, Dongming Yang, Zhiping Li, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101817-101817
Closed Access | Times Cited: 143
Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood–Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2
Xingui Liu, Alexia F. Kalogeropulou, Sofia Domingos, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 37, pp. 16930-16952
Open Access | Times Cited: 107
A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
Rui Qi, Esther Sammler, Claudia P. González-Hunt, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Open Access | Times Cited: 43
Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
François Singh, Alan R. Prescott, Philippa Rosewell, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 100
Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
Heng‐Chung Kung, Kai-Jung Lin, Chia‐Te Kung, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 918-918
Open Access | Times Cited: 93
BNIP3L/NIX regulates both mitophagy and pexophagy
Léa P. Wilhelm, Juan Zapata‐Muñoz, Beatriz Villarejo‐Zori, et al.
The EMBO Journal (2022) Vol. 41, Iss. 24
Open Access | Times Cited: 64
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models
Matthew G Williamson, Marta Madureira, William McGuinness, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 18, pp. 2808-2821
Open Access | Times Cited: 23
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 14
Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson’s disease
Yang Xu, Ge Yan, Jingyu Zhao, et al.
Nano Today (2024) Vol. 58, pp. 102438-102438
Closed Access | Times Cited: 13
DNA Damage and Parkinson’s Disease
Gerd P. Pfeifer
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4187-4187
Open Access | Times Cited: 8
In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models
Li Zhang, Penglu Chen, Tiantian Chen, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 1139-1153
Open Access | Times Cited: 1
The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention
Stephanie M. Boas, Kathlene L. Joyce, Rita M. Cowell
Antioxidants (2021) Vol. 11, Iss. 1, pp. 8-8
Open Access | Times Cited: 43
Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy
Emma V. Rusilowicz-Jones, Francesco G. Barone, Fernanda Martins Lopes, et al.
Life Science Alliance (2021) Vol. 5, Iss. 2, pp. e202101287-e202101287
Open Access | Times Cited: 41
NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson’s Disease
William M. Curtis, William A. Seeds, Mark P. Mattson, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2416-2416
Open Access | Times Cited: 36
DGAT1 activity synchronises with mitophagy to protect cells from metabolic rewiring by iron depletion
Maeve Long, Álvaro Sánchez-Martínez, Marianna Longo, et al.
The EMBO Journal (2022) Vol. 41, Iss. 10
Open Access | Times Cited: 33
Mitophagy and Neurodegeneration: Between the Knowns and the Unknowns
Cuckoo Teresa Jetto, Akshaya Nambiar, Ravi Manjithaya
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 29
PINK1 regulated mitophagy is evident in skeletal muscles
François Singh, Léa P. Wilhelm, Alan R. Prescott, et al.
Autophagy Reports (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Opposing roles for AMPK in regulating distinct mitophagy pathways
Marianna Longo, Aniketh Bishnu, Pierpaolo Risiglione, et al.
Molecular Cell (2024) Vol. 84, Iss. 22, pp. 4350-4367.e9
Open Access | Times Cited: 6
Unraveling neuroprotection in Parkinson’s disease: Nrf2–Keap1 pathway’s vital role amidst pathogenic pathways
Tanzeer Kaur, Palak Sidana, Navpreet Kaur, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2801-2820
Closed Access | Times Cited: 5
Silibinin ameliorates depression/anxiety-like behaviors of Parkinson's disease mouse model and is associated with attenuated STING-IRF3-IFN-β pathway activation and neuroinflammation
Xiumin Liu, Wenhui Chen, Chenkang Wang, et al.
Physiology & Behavior (2021) Vol. 241, pp. 113593-113593
Closed Access | Times Cited: 28
A potential therapeutic approach for ulcerative colitis: targeted regulation of mitochondrial dynamics and mitophagy through phytochemicals
Jianping Zhou, Yanli Xi, Ting Wu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Application of a macrocyclization strategy in kinase inhibitor development
Kun Xing, Shujun Li, Jing Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Genetic variants associated with idiopathic Parkinson’s disease in Latin America: A systematic review
Felipe Duarte-Zambrano, David Felipe Alfonso-Cedeño, Jorge A. Barrero, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Open Access
Crosstalk of organelles in Parkinson’s disease – MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes
Martin Lang, Peter P. Pramstaller, Irene Pichler
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top